NeuroSense Therapeutics and PhaseV have partnered to use causal machine learning to analyze and optimize the planned Phase 3 trial of PrimeC as a…
NeuroSense Therapeutics and PhaseV have partnered to use causal machine learning to analyze and optimize the planned Phase 3 trial of PrimeC as a…
Login below or Register Now.
Already registered? Login.